Lilly's Kisunla™ (donanemab-azbt) Receives Marketing Authorization in Great Britain for the Treatment of Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease in Adult Patients Who Are Apolipoprotein E Ε4 Heterozygotes or Non-Carriers

This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lilly's Stock

MangoRx hits back at Eli Lilly’s weight loss drug copycat claims

Update: Eli Lilly Files Suits Against Companies Selling Weight-Loss Drug

Sector Update: Health Care Stocks Fall Late Afternoon

Novartis Gets CHMP Recommendation for Kisqali in Broader Population

Wall Street analysts initiate coverage of BioAge Labs

The pill form of Ozempic can reduce the risk of heart attacks and strokes, study says

Spirit Airlines, Eli Lilly, Humana-Cigna: 3 Stories In Focus

I'm a pharmacist. Knockoff Ozempic and other weight loss products have serious hidden risks

Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year?

Market Chatter: Eli Lilly Files Suits Against Companies Selling Weight-Loss Drug